2013 Webinar Series
The list of neonatal Complications related to a mother's use of illicit drugs during pregnancy is a long one. This webinar explores the health and neurobehavioral consequences of prenatal drug exposure and provides strategies for interventions and treatment of the baby.
The use of methadone for pregnant women addicted to narcotics has tremendous advantages for pregnancy and child outcome. However, there is a great deal of controversy over the appropriate methadone dose for pregnant women and the treatment of the infant going through opiate abstinence. This webinar reviews the research on high, medium, and low dose methadone maintenance and provides guidelines for treating mother and child.
Women who use illegal drugs are among the highest risk populations for infection with HIV and Hepatitis C, both of which can cross the placenta and infect the fetus. This webinar describes the risk of transplacental infections and how to evaluate, follow, and treat the exposed infant.
Women with a chemical dependence frequently have poor family and social support networks and few positive relationships with other women. These factors contribute to low rates of breastfeeding in women addicted to illicit drugs. However, breastfeeding can enhance the mother/child relationship and is the healthiest means of feeding the infant. This presentation discusses the pros and cons of breastfeeding by women with a history of substance abuse and will provide guidelines that encourage breastfeeding but at the same time protect the newborn from harm by substances that cross into the breast milk.
Many newborns exposed prenatally to illegal drugs end up in the neonatal intensive care unit for days or weeks. This disruption from the family interferes with the attachment and nurturing interactions that are necessary for both mother and child. In addition, the NICU is a scary place, full of technology and language that families don't understand. This webinar discusses strategies for ensuring that families are engaged with their child while in the NICU, understand the various difficulties the child may be having and can deal with the guilt that many mothers might feel when seeing their critically ill child.
The Child Abuse Prevention and Treatment Act (CAPTA) mandates that providers report to the child welfare system any child birth to three years who have been affected by prenatal exposure to an illicit drug or to alcohol. States have had a difficult time implementing this federal legislation, and few physicians, nurses, social workers, and other clinicians understand the law's implications. This webinar examines the current CAPTA legislation, discusses its implications for clinicians and families, and provides guidelines for implementing the law.